Clinical Trials
3 trialsNCT03502785 2025-07-10
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
Inovio Pharmaceuticals
Phase 1/2 Completed
NCT02172911 2021-02-21
A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer
Inovio Pharmaceuticals
Phase 1/2 Completed
NCT02163057 2021-01-22
Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma
Inovio Pharmaceuticals
Phase 1/2 Completed